Inc Research A Cmn (INCR) 44.40 $INCR
Services Stocks on Investors' Radar -- HERC, Myriad Genetics, Qiagen, and INC Research
PR Newswire - Wed Sep 21, 6:30AM CDT
Today, Stock-Callers reviews the performance of these services stocks: HERC Holdings Inc. (NYSE: HRI), Myriad Genetics Inc. (NASDAQ: MYGN), Qiagen NV (NASDAQ: QGEN), and INC Research Holdings Inc. (NASDAQ: INCR). At the close of Tuesday's trading session, the NASDAQ Composite ended the trading session at 5,241.35, up 0.12%; the Dow Jones Industrial Average edged 0.05% higher, to finish at 18,129.96; and the S&P 500 closed at 2,139.76, up 0.03%. Learn more about these stocks by accessing their free research reports at:
MYGN: 21.50 (+0.75), INCR: 44.40 (+0.52), HRI: 32.79 (-0.12), QGEN: 26.87 (+0.42)
The Cooper Companies at 52-Week High on Strong Portfolio
Zacks Equity Research - Zacks Investment Research - Fri Sep 16, 8:53AM CDT
Share price of The Cooper Companies (COO) rallied to a new 52-week high of $190.75 on Sep 15, eventually closing a tad lower at $189.90.
HYH: 34.88 (+0.32), INCR: 44.40 (+0.52), COO: 184.50 (-1.68)
Medidata Solutions & University of Carolina Wilmington Tie Up
Zacks Equity Research - Zacks Investment Research - Thu Sep 15, 9:06AM CDT
Medidata Solutions Inc. (MDSO), a NY-based global provider of clinical and cloud-based solutions for life sciences companies, announced a strategic partnership with University of North Carolina Wilmington.
MDSO: 56.59 (+0.58), INCR: 44.40 (+0.52), LNTH: 9.07 (+0.42), NUVA: 68.06 (+1.06)
Phibro Animal Health Hurt by Threats of Mecadox Suspension
Zacks Equity Research - Zacks Investment Research - Thu Sep 15, 8:47AM CDT
On Sep 13, we issued an updated research report on NJ-based Phibro Animal Health Corporation (PAHC) -- a leading global diversified animal health and mineral nutrition company.
PAHC: 27.71 (+0.82), INCR: 44.40 (+0.52), LNTH: 9.07 (+0.42), NUVA: 68.06 (+1.06)
New Strong Buy Stocks for September 15th
Indradip Ghosh - Zacks Investment Research - Thu Sep 15, 7:44AM CDT
New Strong Buy Stocks for September 15th
STB: 6.04 (unch), NTT: 46.97 (+0.57), ARI: 17.24 (+0.21), INCR: 44.40 (+0.52), URI: 75.39 (-0.27)
INC Research and CISCRP Announce Finalists for "Inspiring Hope" Ideathon
GlobeNewswire - Wed Sep 14, 6:31AM CDT
INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, together with the Center for Information and Study on Clinical Research Participation (CISCRP), a non-profit organization dedicated to engaging the public and patients as partners in the clinical research process, today announced the finalists for the "Inspiring Hope" Ideathon event. In a competition that inspired nearly 70 entries, 14 ideas submitted by teams from around the world have been shortlisted for their potential to help address the critical need to increase awareness of clinical trial participation among patients, healthcare professionals and the general public. Finalists will convene Sept. 27-28 at District Hall in Boston for a crowdsolving-type event where they will further develop and ultimately present their solutions to the judging panel and the 2016 "Inspiring Hope" Award winner will be named.
INCR: 44.40 (+0.52)
5 Medical Services Stocks to Buy Amid Healthcare Anxiety
Zacks Equity Research - Zacks Investment Research - Tue Sep 13, 7:53AM CDT
Let's take a look at the major Medical Service stocks that can endure the broader ailment and duly reward investors.
ABCO: 44.18 (-0.13), BEAT: 18.60 (-0.05), INCR: 44.40 (+0.52), HWAY: 26.42 (+0.79), AHS: 34.58 (+0.08)
INC Research Upgraded to Strong Buy on Estimate Revision
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 8:26AM CDT
On Aug 27, Zacks Investment Research raised INC Research Holdings Inc. (INCR) to a Zacks Rank #1 (Strong Buy).
BABY: 44.38 (+0.59), MASI: 60.32 (+0.47), ABCO: 44.18 (-0.13), INCR: 44.40 (+0.52)
New Strong Buy Stocks for August 29th
Indradip Ghosh - Zacks Investment Research - Mon Aug 29, 7:13AM CDT
New Strong Buy Stocks for August 29th
QRVO: 56.52 (+0.45), SNCR: 41.96 (+0.29), INCR: 44.40 (+0.52), LTXB: 31.90 (+0.33), TREX: 58.56 (+0.67)
INC Research to Present at Upcoming September Conferences
GlobeNewswire - Thu Aug 25, 4:46PM CDT
INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today announced that it will participate in two upcoming investor conferences. Presenting at the conferences will be Greg Rush, Chief Financial Officer.
INCR: 44.40 (+0.52), WFC: 45.72 (-0.11)
Acadia Healthcare (ACHC): Strong Sell on Weak FY16 View
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:31AM CDT
On Aug 24, Zacks Investment Research downgraded Acadia Healthcare Company Inc (ACHC) to a Zacks Rank #5 (Strong Sell).
ACHC: 50.32 (+1.10), INCR: 44.40 (+0.52), AHS: 34.58 (+0.08), WOOF: 69.65 (-0.49)
INC Research Announces Secondary Offering and Repurchase of Common Stock
GlobeNewswire - Tue Aug 16, 3:27PM CDT
INC Research Holdings, Inc. (Nasdaq:INCR) (the "Company"
, a leading global Phase I to Phase IV contract research organization, today announced that certain of its existing stockholders, namely affiliates of Avista Capital Partners, L.P. and affiliates of Ontario Teachers' Pension Plan, intend to offer for sale in an underwritten secondary offering 4,500,000 shares of the Company's common stock (the "Offering" pursuant to the Company's shelf registration statement filed with the Securities and Exchange Commission ("SEC". INC Research will not receive any proceeds from the sale of the shares by the selling stockholders in the Offering.
INCR: 44.40 (+0.52)
Technical Roundup on Services Stocks -- Booz Allen Hamilton, Qiagen, Myriad Genetics, and INC Research
PR Newswire - Tue Aug 02, 9:22AM CDT
Stock-Callers.com redirects investors' attention to the Services sector, which as per U.S. Census Bureau, primarily consists of truck transportation, messenger services and warehousing; information sector services; securities, commodities and other financial investment services; rental and leasing services; health care and social assistance; etc. In focus are the following equities ahead of today's trading session: Booz Allen Hamilton Holding Corp. (NYSE: BAH), Qiagen N.V. (NASDAQ: QGEN), Myriad Genetics Inc. (NASDAQ: MYGN), and INC Research Holdings Inc. (NASDAQ: INCR). Sign up today and download for free the research reports for the stocks covered today at:
MYGN: 21.50 (+0.75), BAH: 31.23 (+0.34), INCR: 44.40 (+0.52), QGEN: 26.87 (+0.42)
INC Research's Jean Chitwood Named to Annual PharmaVOICE 100
GlobeNewswire - Tue Aug 02, 8:31AM CDT
INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced Jean Chitwood, Executive Vice President, Corporate Strategy and Development, has been named to this year's PharmaVOICE 100 list celebrating influential and inspirational leaders throughout the life sciences industry. An executive with INC Research for nearly 10 years, Ms. Chitwood was recognized for her strategic vision, passion and focus on helping her peers advance the Company and build INC Research into a successful global enterprise with an unmatched focus on investigative site relationships.
INCR: 44.40 (+0.52)
INC Research Announces 2016 Analyst and Investor Day
GlobeNewswire - Mon Aug 01, 4:25PM CDT
INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today announced that it will host an Analyst and Investor Day Conference at the NASDAQ Market Site in New York City on Tuesday, Aug. 16, 2016 with management and speaker presentations beginning at 8:00 a.m Eastern Time.
INCR: 44.40 (+0.52)
INC Research Announces Secondary Offering
GlobeNewswire - Mon Aug 01, 5:43AM CDT
INC Research Holdings, Inc. (Nasdaq:INCR) (the "Company", a leading global Phase I to Phase IV contract research organization, today announced that certain of its existing stockholders, namely affiliates of Avista Capital Partners, L.P. and affiliates of Ontario Teachers' Pension Plan, intend to offer for sale in an underwritten secondary offering 5,000,000 shares of the Company's Class A common stock pursuant to the Company's shelf registration statement filed with the Securities and Exchange Commission ("SEC". INC Research will not receive any proceeds from the sale of the shares by the selling stockholders in this offering.
INCR: 44.40 (+0.52)
INC Research Announces Transition of CEO Role from Jamie Macdonald to COO Alistair Macdonald Effective Oct. 1, 2016
GlobeNewswire - Thu Jul 28, 5:40AM CDT
INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced that Chief Executive Officer Jamie Macdonald will transition his role as CEO of the Company effective Oct. 1, 2016, to INC Research's current President and COO Alistair Macdonald. Mr. Alistair Macdonald, who has served as INC's President and COO since January 2013 and held various other leadership roles at the Company since 2002, will become a member of the Company's Board of Directors on Oct. 1. Mr. Jamie Macdonald will step down from the Board of Directors at that time and will continue as Vice Chairman to assist in the transition of his CEO responsibilities until Feb. 28, 2017, reporting to the Chairman of the Board of Directors.
INCR: 44.40 (+0.52)
INC Research Reports Second Quarter 2016 Results
GlobeNewswire - Thu Jul 28, 5:21AM CDT
Highlights
INCR: 44.40 (+0.52)
INC Research and CISCRP Announce Judging Panel, Sponsors and Mentors for "Inspiring Hope" Ideathon Event
GlobeNewswire - Wed Jul 27, 12:43PM CDT
INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, together with the Center for Information and Study on Clinical Research Participation (CISCRP), a non-profit organization dedicated to engaging the public and patients as partners in the clinical research process, today announced the judging panel, sponsors and mentors for the upcoming "Inspiring Hope" Ideathon event, an innovative competition designed to develop effective new ways to increase the awareness of clinical trial participation among patients, healthcare professionals and the general public. The submission of idea applications for the event is ongoing through Aug. 8 with the shortlist of finalists to be announced beginning the week of Aug. 15.
INCR: 44.40 (+0.52)
Active Equities to Watch in the Services Sector -- Booz Allen Hamilton Holding, Qiagen, INC Research Holdings, and Myriad Genetics
PR Newswire - Fri Jun 17, 7:20AM CDT
On Thursday, June 16, 2016, the NASDAQ Composite ended the trading session at 4,844.92, up 0.21%; the Dow Jones Industrial Average advanced 0.53% to finish at 17,733.10; and the S&P 500 closed at 2,077.99, up 0.31%. The gains were broad based as seven out of nine sectors ended the session in positive. Stock-Callers.com has initiated coverage on the following equities: Booz Allen Hamilton Holding Corporation (NYSE: BAH), Qiagen N.V. (NASDAQ: QGEN), INC Research Holdings Inc. (NASDAQ: INCR), and Myriad Genetics Inc. (NASDAQ: MYGN). Learn more about these stocks by accessing their free trade alerts at:
MYGN: 21.50 (+0.75), BAH: 31.23 (+0.34), INCR: 44.40 (+0.52), QGEN: 26.87 (+0.42)
Services Stocks on Investors' Radar -- HERC, Myriad Genetics, Qiagen, and INC Research
PR Newswire - Wed Sep 21, 6:30AM CDT
Today, Stock-Callers reviews the performance of these services stocks: HERC Holdings Inc. (NYSE: HRI), Myriad Genetics Inc. (NASDAQ: MYGN), Qiagen NV (NASDAQ: QGEN), and INC Research Holdings Inc. (NASDAQ: INCR). At the close of Tuesday's trading session, the NASDAQ Composite ended the trading session at 5,241.35, up 0.12%; the Dow Jones Industrial Average edged 0.05% higher, to finish at 18,129.96; and the S&P 500 closed at 2,139.76, up 0.03%. Learn more about these stocks by accessing their free research reports at:
MYGN: 21.50 (+0.75), INCR: 44.40 (+0.52), HRI: 32.79 (-0.12), QGEN: 26.87 (+0.42)
The Cooper Companies at 52-Week High on Strong Portfolio
Zacks Equity Research - Zacks Investment Research - Fri Sep 16, 8:53AM CDT
Share price of The Cooper Companies (COO) rallied to a new 52-week high of $190.75 on Sep 15, eventually closing a tad lower at $189.90.
HYH: 34.88 (+0.32), INCR: 44.40 (+0.52), COO: 184.50 (-1.68)
Medidata Solutions & University of Carolina Wilmington Tie Up
Zacks Equity Research - Zacks Investment Research - Thu Sep 15, 9:06AM CDT
Medidata Solutions Inc. (MDSO), a NY-based global provider of clinical and cloud-based solutions for life sciences companies, announced a strategic partnership with University of North Carolina Wilmington.
MDSO: 56.59 (+0.58), INCR: 44.40 (+0.52), LNTH: 9.07 (+0.42), NUVA: 68.06 (+1.06)
Phibro Animal Health Hurt by Threats of Mecadox Suspension
Zacks Equity Research - Zacks Investment Research - Thu Sep 15, 8:47AM CDT
On Sep 13, we issued an updated research report on NJ-based Phibro Animal Health Corporation (PAHC) -- a leading global diversified animal health and mineral nutrition company.
PAHC: 27.71 (+0.82), INCR: 44.40 (+0.52), LNTH: 9.07 (+0.42), NUVA: 68.06 (+1.06)
New Strong Buy Stocks for September 15th
Indradip Ghosh - Zacks Investment Research - Thu Sep 15, 7:44AM CDT
New Strong Buy Stocks for September 15th
STB: 6.04 (unch), NTT: 46.97 (+0.57), ARI: 17.24 (+0.21), INCR: 44.40 (+0.52), URI: 75.39 (-0.27)
INC Research and CISCRP Announce Finalists for "Inspiring Hope" Ideathon
GlobeNewswire - Wed Sep 14, 6:31AM CDT
INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, together with the Center for Information and Study on Clinical Research Participation (CISCRP), a non-profit organization dedicated to engaging the public and patients as partners in the clinical research process, today announced the finalists for the "Inspiring Hope" Ideathon event. In a competition that inspired nearly 70 entries, 14 ideas submitted by teams from around the world have been shortlisted for their potential to help address the critical need to increase awareness of clinical trial participation among patients, healthcare professionals and the general public. Finalists will convene Sept. 27-28 at District Hall in Boston for a crowdsolving-type event where they will further develop and ultimately present their solutions to the judging panel and the 2016 "Inspiring Hope" Award winner will be named.
INCR: 44.40 (+0.52)
5 Medical Services Stocks to Buy Amid Healthcare Anxiety
Zacks Equity Research - Zacks Investment Research - Tue Sep 13, 7:53AM CDT
Let's take a look at the major Medical Service stocks that can endure the broader ailment and duly reward investors.
ABCO: 44.18 (-0.13), BEAT: 18.60 (-0.05), INCR: 44.40 (+0.52), HWAY: 26.42 (+0.79), AHS: 34.58 (+0.08)
INC Research Upgraded to Strong Buy on Estimate Revision
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 8:26AM CDT
On Aug 27, Zacks Investment Research raised INC Research Holdings Inc. (INCR) to a Zacks Rank #1 (Strong Buy).
BABY: 44.38 (+0.59), MASI: 60.32 (+0.47), ABCO: 44.18 (-0.13), INCR: 44.40 (+0.52)
New Strong Buy Stocks for August 29th
Indradip Ghosh - Zacks Investment Research - Mon Aug 29, 7:13AM CDT
New Strong Buy Stocks for August 29th
QRVO: 56.52 (+0.45), SNCR: 41.96 (+0.29), INCR: 44.40 (+0.52), LTXB: 31.90 (+0.33), TREX: 58.56 (+0.67)
INC Research to Present at Upcoming September Conferences
GlobeNewswire - Thu Aug 25, 4:46PM CDT
INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today announced that it will participate in two upcoming investor conferences. Presenting at the conferences will be Greg Rush, Chief Financial Officer.
INCR: 44.40 (+0.52), WFC: 45.72 (-0.11)
Acadia Healthcare (ACHC): Strong Sell on Weak FY16 View
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:31AM CDT
On Aug 24, Zacks Investment Research downgraded Acadia Healthcare Company Inc (ACHC) to a Zacks Rank #5 (Strong Sell).
ACHC: 50.32 (+1.10), INCR: 44.40 (+0.52), AHS: 34.58 (+0.08), WOOF: 69.65 (-0.49)
INC Research Announces Secondary Offering and Repurchase of Common Stock
GlobeNewswire - Tue Aug 16, 3:27PM CDT
INC Research Holdings, Inc. (Nasdaq:INCR) (the "Company"
, a leading global Phase I to Phase IV contract research organization, today announced that certain of its existing stockholders, namely affiliates of Avista Capital Partners, L.P. and affiliates of Ontario Teachers' Pension Plan, intend to offer for sale in an underwritten secondary offering 4,500,000 shares of the Company's common stock (the "Offering" pursuant to the Company's shelf registration statement filed with the Securities and Exchange Commission ("SEC". INC Research will not receive any proceeds from the sale of the shares by the selling stockholders in the Offering. INCR: 44.40 (+0.52)
Technical Roundup on Services Stocks -- Booz Allen Hamilton, Qiagen, Myriad Genetics, and INC Research
PR Newswire - Tue Aug 02, 9:22AM CDT
Stock-Callers.com redirects investors' attention to the Services sector, which as per U.S. Census Bureau, primarily consists of truck transportation, messenger services and warehousing; information sector services; securities, commodities and other financial investment services; rental and leasing services; health care and social assistance; etc. In focus are the following equities ahead of today's trading session: Booz Allen Hamilton Holding Corp. (NYSE: BAH), Qiagen N.V. (NASDAQ: QGEN), Myriad Genetics Inc. (NASDAQ: MYGN), and INC Research Holdings Inc. (NASDAQ: INCR). Sign up today and download for free the research reports for the stocks covered today at:
MYGN: 21.50 (+0.75), BAH: 31.23 (+0.34), INCR: 44.40 (+0.52), QGEN: 26.87 (+0.42)
INC Research's Jean Chitwood Named to Annual PharmaVOICE 100
GlobeNewswire - Tue Aug 02, 8:31AM CDT
INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced Jean Chitwood, Executive Vice President, Corporate Strategy and Development, has been named to this year's PharmaVOICE 100 list celebrating influential and inspirational leaders throughout the life sciences industry. An executive with INC Research for nearly 10 years, Ms. Chitwood was recognized for her strategic vision, passion and focus on helping her peers advance the Company and build INC Research into a successful global enterprise with an unmatched focus on investigative site relationships.
INCR: 44.40 (+0.52)
INC Research Announces 2016 Analyst and Investor Day
GlobeNewswire - Mon Aug 01, 4:25PM CDT
INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today announced that it will host an Analyst and Investor Day Conference at the NASDAQ Market Site in New York City on Tuesday, Aug. 16, 2016 with management and speaker presentations beginning at 8:00 a.m Eastern Time.
INCR: 44.40 (+0.52)
INC Research Announces Secondary Offering
GlobeNewswire - Mon Aug 01, 5:43AM CDT
INC Research Holdings, Inc. (Nasdaq:INCR) (the "Company"
, a leading global Phase I to Phase IV contract research organization, today announced that certain of its existing stockholders, namely affiliates of Avista Capital Partners, L.P. and affiliates of Ontario Teachers' Pension Plan, intend to offer for sale in an underwritten secondary offering 5,000,000 shares of the Company's Class A common stock pursuant to the Company's shelf registration statement filed with the Securities and Exchange Commission ("SEC". INC Research will not receive any proceeds from the sale of the shares by the selling stockholders in this offering. INCR: 44.40 (+0.52)
INC Research Announces Transition of CEO Role from Jamie Macdonald to COO Alistair Macdonald Effective Oct. 1, 2016
GlobeNewswire - Thu Jul 28, 5:40AM CDT
INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced that Chief Executive Officer Jamie Macdonald will transition his role as CEO of the Company effective Oct. 1, 2016, to INC Research's current President and COO Alistair Macdonald. Mr. Alistair Macdonald, who has served as INC's President and COO since January 2013 and held various other leadership roles at the Company since 2002, will become a member of the Company's Board of Directors on Oct. 1. Mr. Jamie Macdonald will step down from the Board of Directors at that time and will continue as Vice Chairman to assist in the transition of his CEO responsibilities until Feb. 28, 2017, reporting to the Chairman of the Board of Directors.
INCR: 44.40 (+0.52)
INC Research Reports Second Quarter 2016 Results
GlobeNewswire - Thu Jul 28, 5:21AM CDT
Highlights
INCR: 44.40 (+0.52)
INC Research and CISCRP Announce Judging Panel, Sponsors and Mentors for "Inspiring Hope" Ideathon Event
GlobeNewswire - Wed Jul 27, 12:43PM CDT
INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, together with the Center for Information and Study on Clinical Research Participation (CISCRP), a non-profit organization dedicated to engaging the public and patients as partners in the clinical research process, today announced the judging panel, sponsors and mentors for the upcoming "Inspiring Hope" Ideathon event, an innovative competition designed to develop effective new ways to increase the awareness of clinical trial participation among patients, healthcare professionals and the general public. The submission of idea applications for the event is ongoing through Aug. 8 with the shortlist of finalists to be announced beginning the week of Aug. 15.
INCR: 44.40 (+0.52)
Active Equities to Watch in the Services Sector -- Booz Allen Hamilton Holding, Qiagen, INC Research Holdings, and Myriad Genetics
PR Newswire - Fri Jun 17, 7:20AM CDT
On Thursday, June 16, 2016, the NASDAQ Composite ended the trading session at 4,844.92, up 0.21%; the Dow Jones Industrial Average advanced 0.53% to finish at 17,733.10; and the S&P 500 closed at 2,077.99, up 0.31%. The gains were broad based as seven out of nine sectors ended the session in positive. Stock-Callers.com has initiated coverage on the following equities: Booz Allen Hamilton Holding Corporation (NYSE: BAH), Qiagen N.V. (NASDAQ: QGEN), INC Research Holdings Inc. (NASDAQ: INCR), and Myriad Genetics Inc. (NASDAQ: MYGN). Learn more about these stocks by accessing their free trade alerts at:
MYGN: 21.50 (+0.75), BAH: 31.23 (+0.34), INCR: 44.40 (+0.52), QGEN: 26.87 (+0.42)
